View the event
| Reference: | 3532 |
| Country: | India |
| Multiple country event: | No |
| Region: | SEARO |
| City: | Bangalore |
| Start date: | 25 August 2011 |
| End date: | 26 August 2011 |
| Estimated duration: | 2 days |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | TB diagnostics in India: A 2-day conference to stimulate industry/biotech engagement in TB diagnostics innovations in India |
| Type: | Conference (open - ouvert) |
| Terms of Reference: | Context and rationale
The scale up of DOTS in India is a great public health accomplishment, and yet undiagnosed and poorly managed TB continues to fuel the epidemic. Recognizing these challenges, the Government of India has set an ambitious goal of providing universal access to quality diagnosis and treatment for all TB patients in the country. Innovative tools and delivery systems in both the public and private sectors are critical for reaching this goal. The current in-vitro diagnostics market in India is dominated by imported and generic products, with virtually no innovations. But India has the potential to solve its TB problem with “home-grown” solutions. Just as Indian pharma and biotech companies revolutionized access to high-quality, affordable AIDS drugs and hepatitis vaccines through generic production, Indian diagnostic companies could also become the world’s hub for high-quality generic diagnostics. India also has the potential to lead the world in developing innovative TB diagnostics. For this to happen, Indian industry must move from the import and imitation approach to genuine innovation in both product development as well as delivery. This will require permissive policies, enhanced funding, and greater collaboration between government, donors, researchers and the private industry.
Content and themes
This conference will convene industry leaders, innovative thinkers, researchers, funders, TB controllers and policy makers, to stimulate increased industry/biotech engagement in diagnostic innovations that can help TB control in India and elsewhere. Sessions will focus on topics such as market size for TB diagnostics, IVD market analysis and value chain, target product profiles and market needs, frugal innovation and affordable diagnostics, intellectual property issues, regulation of diagnostics, sources of funding, prize models, business models for engaging private sector, scientific obstacles for R&D, barriers to innovation in India, improving academia-industry relations, and role of emerging economies and BRICS in the next wave of TB innovations.
Limited spaces. Industry/biotech participants and TB diagnostic developers will get preference.
Registration form available at:
http://www.sjri.res.in/html/2days_conference_new.html
Conference flyer attached – please distribute/share!
|
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | Other |
| Purpose 2: | |
| Purpose 3: | |
| Other purpose: | |
|
| Entered by: | Other |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | http://www.sjri.res.in/html/2days_conference_new.html |
| Contact email: | http://www.sjri.res.in/html/2days_conference_new.html |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | CIDA |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | Conference flyer attached – please distribute/share!
|
| |
There are no experts (roster) associated with this event. There are no experts (non-roster) associated with this event.
Date Created: 23 May 2011
Entered By: TBTEAM Admin
|
